Andrew N Schiff
Director · 2 filings · Latest: Jun 11, 2026
Aclaris Therapeutics, Inc.
Monte Rosa Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
ACRS | Andrew N Schiff | Director | Jun 5, 2026 | Option Exercise | — | 11,580 | — | 25,540 |